The pharmacokinetics of the novel anticancer agent, flavone acetic acid (FAA) were investigated in Balb-c mice treated with i.v. doses of 100 mg/kg or 300 mg/kg, using an HPLC assay. The kinetics of disappearance from plasma was monoexponential and dose-dependent. After 100 mg/kg, the plasma peak le
Flavone acetic acid: a nonlinear pharmacokinetic model
โ Scribed by Alain Gouyette; David J. Kerr; Stan B. Kaye; Albert Setanoians; James Cassidy; Christopher Bradley; Gordon Forrest; Mike Soukop
- Book ID
- 104687117
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 469 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
โฆ Synopsis
Flavone acetic acid pharmacokinetics were studied in 31 patients in a phase I clinical trial. The drug was given by i.v. infusions over 1, 1.5, 3, and 6 h at doses ranging from 0.5 to 6.4 g/m2. The pharmacokinetic parameters were determined according to a nonlinear model including Michaelis-Menten-type kinetics. The mean elimination half-life is 4.8 h and the mean volume of distribution of the central compartment, 7.61. Our model predicted a maximal tolerated dose (MTD) of 11.1 g/m2 on the basis of the "therapeutic window" concept, very close to the clinically observed MTD of 10 g/m2. This model is also operational when different protocols of inoculation are considered, such as a divided-dose schedule vs a unique infusion, and indicates that, at the MTD, injections should be made every 72 h to avoid drug accumulation.
๐ SIMILAR VOLUMES